Information  X 
Enter a valid email address
  Print          More announcements

Thursday 10 June, 2021

JP Morgan Sec LLC

Willis Towers Watson plc 8.3 AMEND

RNS Number : 5572B
J.P. Morgan Securities LLC
10 June 2021
 

Ap19

 

 

  AMENDMENT

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

25 May 2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

1,913,212  1.48

 

1,560,908  1.21

 

(2) Derivatives (other than options)

1,396,480  1.08

 

1,743,338  1.35

 

(3)Optionsandagreementstopurchase/sell

  0.00

 

  0.00

 

Total

3,309,692  2.56

 

3,304,246  2.56

 

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit(USD)

 

(Note 5)

Sale (Borrow Return)

 

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

 

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

200

 

27

 7,902

 145

 2

 44

 578

 400

 36

 3

 3

 4

 25

 200

 48

 175

 12

 193

 53

 14

 100

 12

 6

 13

 200

 4

 4

 

 10,328

 100

 94

 1,506

 104

 100

 100

 199

 2

 2

 1

 200

 193

 1

 2

 1

 48,194

 4

N/A

 

261.5885  USD

261.5900  USD

261.6259  USD

261.6350  USD

261.6600  USD

261.6687  USD

261.7300  USD

261.7400  USD

261.7467  USD

261.7500  USD

261.7650  USD

261.7748  USD

261.8500  USD

261.8600  USD

261.8837  USD

261.8851  USD

261.8900  USD

261.9792  USD

261.9817  USD

262.0267  USD

262.4521  USD

262.7083  USD

262.8358  USD

262.9200  USD

263.8000  USD

263.8225  USD

 

261.5900  USD

261.6000  USD

261.6300  USD

261.6423  USD

261.6674  USD

261.6700  USD

261.7000  USD

261.7246  USD

261.7480  USD

261.7550  USD

261.8100  USD

261.8500  USD

261.8900  USD

262.5300  USD

262.6550  USD

262.7900  USD

262.9200  USD

263.8225  USD

 

 

 

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD) (Note 5)

Equity Swap

 

 

Decrease Long

4

263.8237

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form   or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

 

  None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

  10 June 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEURVNRARUNAAR

a d v e r t i s e m e n t